Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Oncology: Nintedanib esilate (Ofev) is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after failure of first line chemotherapy.
Idiopathic Pulmonary Fibrosis (IPF), other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype and Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD): Nintedanib esilate (Ofev) is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Nintedanib esilate (Ofev) is also indicated for the treatment of other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype (see Pharmacology: Pharmacodynamics: Clinical trials under Actions).
Nintedanib esilate (Ofev) is indicated for the treatment of Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD).

Ofev Indications/Uses

nintedanib

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug

Marketer:

Boehringer Ingelheim